PK and Safety of SI-722 in IC/BPS

NCT04208087 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Cystitis
Bladder Pain Syndrome

Interventions

DRUG: SI-722
DRUG: Placebo

Sponsor

Seikagaku Corporation